SciELO - Scientific Electronic Library Online

vol.27 issue1Validated high performance thin layer chromatography method for simultaneous determination of quercetin and gallic acid in Leea indicaLaboratory evaluation of Clusia fluminensis extracts and their isolated compounds against Dysdercus peruvianus and Oncopeltus fasciatus author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista Brasileira de Farmacognosia

Print version ISSN 0102-695XOn-line version ISSN 1981-528X

Rev. bras. farmacogn. vol.27 no.1 Curitiba Jan./Feb. 2017 

Original articles

Paniculatumoside G, a new C21 steroidal glycoside from Cynanchum paniculatum

Hua Gao1 

Wei Wang*  1 

Wenxi Chu1 

Kun Liu1 

Yang Liu1 

Xiaohong Liu1 

Huili Yao1 

Qi Gao1 

1School of Pharmacy, Qingdao University, Qingdao, People's Republic of China


A new C21 steroidal glycoside, paniculatumoside G, together with neocynapanogenin C isolated for the first time from the natural source and two known compounds were isolated and characterized from the roots and rhizomes of Cynanchum paniculatum (Bunge) Kitag. ex H.Hara, Apocynaceae, a commonly used Traditional Chinese Medicine. On the basis of spectroscopic analysis, including HR-ESI-MS, 1D and 2D NMR spectral data, the structure of the new C21 steroidal glycoside was elucidated as neocynapanogenin H 3-O-β-D-oleandropyranoside.

Keywords: Asclepiadaceae; Cynanchum paniculatum; C21 steroidal glycoside; Neocynapanogenin H 3-O-β-D-oleandropyranoside


Cynanchum paniculatum (Bunge) Kitag. ex H.Hara, Apocynaceae, a perennial herb native to east Asia, is commonly called ‘Xu Chang Qing’ in Chinese, and has been used as a Traditional Chinese Medicine for the treatment of peratodynia, gastroenteritis, venomous snake bite, and ascites (Jiang and Li, 1977). Previous phytochemical investigations on C. paniculatum have revealed the presence of phenolic derivatives, alkaloids, flavonoids, polysaccharides, triterpenoids, and C21 steroidal glycosides (Niu et al., 2015; Fu et al., 2015). The reported bioactivities of the plant extracts and isolated constituents include anti-adipogenic (Jang et al., 2014), neuroprotective (Weon et al., 2013), anti-tumor (Kim et al., 2012), anti-inflammatory, anti-nociceptive, sedative (Choi et al., 2006), araricidal (Kim et al., 2013a), and herpes simplex encephalitis inducing impairment preventive activities (Li et al., 2012). Our previous phytochemical investigation on ethanol extract of this source resulted in the isolation of nine C21 steroidal aglycones and glycosides (Chu et al., 2015). In our continuing study on this source, one new steroidal glycoside (1) together with three known compounds (24) were isolated and identified. It should be noted that compound 2 was isolated for the first time from the natural source. Their structures were elucidated by detailed interpretation of NMR and MS data.

Materials and methods

General experimental procedures

Optical rotations were measured by using a JASCO P-1020 automatic digital polarimeter (JASCO Corporation, Tokyo, Japan). The NMR spectral data were recorded on a Bruker AV-500 FT-NMR (500 MHz for 1H and 125 MHz for 13C) in C5D5N, using visual C5D5N resonances (1H δ 7.21, 7.58, and 8.73, 13C δ 123.5, 135.5, and 149.0) for internal reference. All chemical shifts (δ) are given in ppm. HR-ESI-MS and ESI-MS were obtained with a Bruker microTOFQ mass spectrometer (Bruker Daltonics, Bremen, Germany). Column chromatography was performed with macroporous resin HPD100 (Cangzhou Bon Adsorber Technology Co., Ltd, Cangzhou, China) and RP-18 reversed-phase silica gel (S-50 mm, YMC, Kyoto, Japan). TLC analysis was carried out on pre-coated TLC plates with silica gel RP-18 60 F254 (Merck, Darmstadt, Germany, 0.25 mm). Detection was achieved by spraying with 10% H2SO4 in MeOH followed by heating. Preparative HPLC was performed on a NP7005C pump connected with a SHODEX RI-102 detector (Shoko Scientific Co., Ltd, Tokohama, Japan), using Megres ODS column (250 mm × 10 mm, i.d., 5 µm, Hanbang Sci. & Tech., Haian, China). HPLC-grade MeOH was purchased from Merck. HPLC-grade water was purified using a Milli-Q system (millipore, Boston, MA, USA). All solvents used for the chromatographic separations were distilled before use.

Plant material

The roots and rhizomes of Cynanchum paniculatum (Bunge) Kitag. ex H.Hara, Apocynaceae, were obtained in Jingde Pharmaceutical Company, Bozhou, Anhui Province of China, and identified by Prof. Baomin Feng, Dalian University, China. A voucher specimen (CPXCQ-2014-03) was deposited at the College of Pharmacy, Qingdao University, China.

Extraction and isolation

The roots and rhizomes of C. paniculatum (10 kg) were reflux extracted twice with 90% ethanol for 1.5 h and the solvent was evaporated under reduced pressure to give an EtOH extract (1.5 kg). The EtOH extract (1.2 kg) was dissolved with water and subjected to column chromatography on HPD-100 macroporous resin and eluted with EtOH-H2O (0:100, 30:70, 70:30, and 95:5), successively. The fraction eluted with 70% ethanol (100 g) was chromatographed over a D941 macroporous resin column, eluting with 95% ethanol and a total of 15 g residue was collected. The residue was chromatographed further on a RP-C18 silica gel and eluted with a gradient increasing MeOH (30–80%) in water to give sixteen subfractions (Fr.C1–C16) on the basis of TLC analyses. Fr.C14 was purified by preparative HPLC using MeOH/H2O (60:40) at a flow rate of 2 ml/min (Megres C18 column, 250 mm × 10.0 mm, 5 µm) to yield compound 1 (4.91 mg, tR = 41.0 min). Compound 2 (5.60 mg, tR = 16.0 min) and compound 3 (8.25 mg, tR = 60.0 min) were obtained from Fr.C13 and Fr.C12 by preparative HPLC (Megres C18 column, 250 mm × 10.0 mm, 5 µm; flow rate, 2.0 ml/min) employing MeOH/H2O (55:45) and MeOH/H2O (52:48) as the mobile phase, respectively. The fraction eluted with 95% ethanol (10 g) was separated chromatographically on a RP-C18 silica gel to get five subfractions (Fr.C1′–C5′) on the basis of TLC analysis. Fr.C4′ was isolated by preparative HPLC using MeOH/H2O (60:40) at a flow rate of 1.6 ml/min (Megres C18 column, 250 mm × 10.0 mm, 5 µm) to yield compound 4 (62.29 mg, tR = 140 min).

Spectral data

Neocynapanogenin H 3-O-β- D-oleandropyranoside (1): An amorphous powder; [α]D25 +45.7 (c 0.01, MeOH); 1H-(C5D5N, 500 MHz) and 13C-NMR (C5D5N, 125 MHz) see Table 1; HR-ESI-MS m/z 573.2667 [M+Na]+ (calcd for C29H42NaO10, 573.2676).

Table 1 1H-NMR and 13C-NMR spectral data of compound 1 (500 and 125 MHz, C5D5N, δ ppm, J in Hz). 

Position 1 Paniculatumoside Aa
δH δC δC
1α 1.40 (t, J = 12.2 Hz) 45.5 (t) 37.2 (t)
1β 2.42 (dd, J = 13.0, 4.6 Hz)
2 4.02 (ddd, J = 12.6, 9.0, 4.6 Hz) 70.0 (d) 29.7 (t)
3 3.69 (m) 84.8 (d) 77.0 (d)
4α 2.65 (m) 37.5 (t) 39.1 (t)
4β 2.59 (m)
5 139.4 (s) 140.3 (s)
6 5.43 (m) 120.4 (d) 120.1 (d)
7α 2.62 (m) 29.2 (t) 30.4 (t)
7β 2.50 (m)
8 2.47 (m) 40.9 (d) 41.4 (d)
9 2.13 (td, J = 11.4, 5.2 Hz) 51.9 (d) 52.1 (d)
10 38.6 (s) 37.8 (s)
11α 2.55 (m) 30.4 (t) 30.3 (t)
11β 2.29 (ddd, J = 11.9, 7.4, 4.4 Hz)
12 5.47 (m) 131.0 (d) 133.2 (d)
13 142.3 (s) 139.4 (s)
14 179.3 (s) 179.4 (s)
15α 4.42 (dd, J = 9.9, 7.4 Hz) 70.4 (t) 70.5 (t)
15β 4.14 (dd, J = 10.0, 4.8 Hz)
16 5.74 (ddd, J = 8.1, 7.4, 4.8 Hz) 78.1 (d) 78.0 (d)
17 3.29 (d, J = 8.1 Hz) 56.1 (d) 56.0 (d)
18 5.62 (s) 104.3 (d) 107.3 (d)
19 1.09 (s) 20.6 (q) 19.6 (q)
20 114.6 (s) 115.1 (s)
21 1.73 (s) 24.3 (q) 24.3 (q)
18-OCH3 3.50 (s) 55.0 (q)
1′(Ole) 4.84 (dd, J = 9.8, 1.8 Hz) 99.3 (d) 98.3 (d)
2′α 2.59 (m) 37.3 (t) 37.5 (t)
2′β 1.78 (ddd, J = 12.0, 9.8, 4.5 Hz)
3′ 3.51 (m) 81.5 (d) 81.7 (d)
4′ 3.46 (m) 76.1 (d) 76.5 (d)
5′ 3.65 (m) 73.1 (d) 72.9 (d)
6′ 1.56 (d, J = 6.1 Hz) 18.4 (q) 18.8 (q)
3′-OCH3 3.49 (s) 57.1 (q) 57.1 (q)

aData from Li et al. (2004).

Neocynapanogenin C (2): An amorphous powder; [α]D25 -65.4 (c 0.01, MeOH); 1H- (C5D5N, 500 MHz) and 13C-NMR (C5D5N, 125 MHz) see Table 2; HR-ESI-MS m/z 399.1783 [M+Na]+ (calcd for C21H28NaO6, 399.1784).

Table 2 1H-NMR and 13C-NMR spectral data of compound 2 (500 and 125 MHz, C5D5N, δ ppm, J in Hz). 

Position δH δC
1 1.17 (m) 37.6 (t)
1.83 (m)
2 1.74 (m) 32.5 (t)
2.08 (m)
3 3.82 (m) 70.7 (d)
4 2.54 (m) 43.1 (t)
2.62 (m)
5 141.1 (s)
6 5.34 (br d, J = 4.6 Hz) 119.4 (d)
7 2.58 (m) 29.1 (t)
2.90 (q, J = 12.2 Hz)
8 2.52 (m) 41.6 (d)
9 2.08 (m) 52.2 (d)
10 37.7 (s)
11 2.27 (m) 30.4 (t)
2.51 (m)
12 5.55 (d, J = 11.0 Hz) 130.2 (d)
13 145.5 (s)
14 179.6 (s)
15 4.16 (dd, J = 9.8, 5.0 Hz) 70.0 (t)
4.39 (dd, J = 9.8, 7.2 Hz)
16 5.77 (ddd, J = 8.1, 7.7, 5.2 Hz) 78.3 (d)
17 3.38 (d, J = 8.1 Hz) 56.8 (d)
18 6.33 (br d, J = 6.0 Hz) 98.7 (d)
19 1.04 (s) 19.8 (q)
20 113.6 (s)
21 1.84 (s) 25.0 (q)

Results and discussion

Compound 1 was obtained as white amorphous powder, and showed positive Liebermann–Burchard and Keller–Kiliani reactions, suggesting it to be a steroidal glycoside with a 2-deoxysugar moiety (Zhu et al., 1999). Its molecular formula was determined as C29H42O10 on the basis of positive HR-ESI-MS adduction [M+Na]+ at m/z 573.2667 (calcd for C29H42NaO10: 573.2676), which was further supported by the 1H- and 13C-NMR spectral data (Table 1). The 13C-NMR and DEPT spectra revealed 29 carbon signals due to five methyl carbons, six methylene carbons, thirteen methine carbons, and five nonprotonated carbons, of which 22 carbons were assigned to the aglycone part including two tertiary methyl carbons (δC 20.6 and 24.3), one methoxyl carbon (δC 55.0), one oxygenated methylene carbon (δC 70.4), four oxygenated methine carbons (δC 70.0, 78.1, 84.8, and 104.3), four olefinic carbons (δC 120.4, 131.0, 139.4 and 142.3), one acetalic carbon (δC 114.6), and one carbonyl carbon (δC 179.3), which exhibited the characteristics of 13,14:14,15-disecopregnane-type steroidal glycoside. The 1H-NMR spectrum of the aglycone moiety showed two angular methyl protons at δH 1.09 (3H, s) and 1.73 (3H, s), two geminal coupled oxygenated-methylene protons at δH 4.14 (1H, dd, J = 10.0, 4.8 Hz) and 4.42 (1H, dd, J = 9.9, 7.4 Hz), four oxygen-substituted methine protons at δH 3.69 (1H, m), 4.02 (1H, ddd, J = 12.6, 9.0, 4.6 Hz), 5.62 (1H, s), and 5.74 (1H, ddd, J = 8.1, 7.4, 4.8 Hz), together with two olefinic protons at δH 5.43 (1H, m) and 5.47 (1H, m). In addition, one methoxy group resonated at δH 3.50 (3H, s) was observed in the 1H-NMR spectrum of the aglycone moiety. Comparison of the aglycone spectral data of 1 with those of neocynapanogenin C, the aglycone of paniculatumoside B (Li et al., 2004), the main differences were the presence of signal for an additional methoxyl (δH/C 3.50/55.0) and the changes of the chemical shifts in C-1 (+8.2 ppm), C-2 (+39.7 ppm), and C-3 (+7.7 ppm), as well as in C-18 (+5.6 ppm) and C-13 (-3.4 ppm) in the NMR spectra of 1. The aglycone moiety of compound 1 was therefore proposed to be a 2-hydroxyl-18-methoxyl derivative of neocynapanogenin C, which were proved by the HMBC correlations from δH 1.40 and 2.42 (H-1) to δC 70.0 (C-2), 84.8 (C-3), 139.4 (C-5), 38.6 (C-10), 20.6 (C-19), from δH 2.59 and 2.65 (H-4) to δC 70.0 (C-2), 84.8 (C-3), 139.4 (C-5), 120.4 (C-6), 38.6 (C-10), and from δH 3.50 (18-OCH3) to δC 104.3 (C-18) (Fig. 1). The relative configuration of the aglycone was elucidated by the NOESY spectrum and the vicinal proton-proton coupling constant. The coupling constant between H-2 and H-3 (9.0 Hz) was typical for trans-diaxial protons, indicating that both oxygenated substituents were equatorial. Observed 1,3-diaxial NOE correlations for H-2/H-4β, H-2/H-19, H-4β/H-19 and H-1α/H-3 (Fig. 2) further supported the β-orientation of H-2 and α-orientation of H-3 and revealed the chair conformation of the A ring. The trans-diaxial relationship of H-8 and H-9, namely, the β-orientation of H-8 and α-orientation of H-9, was suggested by the splitting pattern of H-9 (td, J = 11.4, 5.2 Hz) and the NOESY correlations for H-8/H-19 and H-1α/H-9 (Bai et al., 2005). In addition, the NOE correlation from the methoxyl group at C-18 to H3-21 confirmed the methoxyl group at C-18 as α-orientation. Thus the structure for the aglycone of compound 1 was deduced and a trivial name neocynapanogenin H was assigned. Proton signals were also assigned to one secondary methyl group at δH 1.56 (d, J = 6.1 Hz), one methoxyl group at δH 3.49 (s), and one anomeric proton at δH 4.84 (dd, J = 9.8, 1.8 Hz), whose multiplicities suggested the presence of one 2,6-dideoxy-sugar in a saccharide chain and β-configuration of the hexose unit. The 13C NMR and DEPT data indicated the existence of one oleandropyranosyl unit. It was confirmed by the observed DQFCOSY and HMBC correlations. For the deoxysugars, since only D-form authentic samples could be obtained, their absolute configurations could not be assigned by GC analysis, but determined to be D-forms by comparison of their 13C-NMR spectroscopic data with those reported data. The most significant differences in the 13C-NMR data between D- and L-configuration oleandropyranosyl involve the resonances of C-2. The chemical shift of C-2 in the L-oleandropyranosyl is less than 35 ppm, but that of C-2 in the D-oleandropyranosyl appears above 36 ppm. Therefore, the oleandropyranosyl unit of 1 was determined to be D-configuration based on its 13C-NMR chemical shift of C-2 at 37.3 ppm (Table 1) (Li et al., 2004; Ma et al., 2007; Yang et al., 2011; Kim et al., 2013b), and its location was determined to be C-3 by the H-1′/C-3 HMBC correlation (Fig. 1). Thus, the structure of 1 was finally established as neocynapanogenin H 3-O-β-D-oleandropyranoside.

Fig. 1 Key HMBC correlations of compound 1

Fig. 2 Key NOESY correlations of compound 1

Compound 2 was obtained as white amorphous powder, and showed positive Liebermann–Burchard reaction. Its molecular formula was determined as C21H28O6 on the basis of positive HR-ESI-MS adduction [M+Na]+ at m/z 399.1783 (calcd for C21H28NaO6: 399.1784), which was further supported by the 1H-NMR and 13C-NMR data (Table 2). The 1H-NMR data showed two olefinic protons at δH 5.34 (1H, br d, J = 4.6 Hz) and 5.55 (1H, d, J = 11.0 Hz), three oxygen-substituted methine protons at δH 3.82 (1H, m), 5.77 (1H, ddd, J = 8.1, 7.7, 5.2 Hz), and 6.33 (1H, br d, J = 6.0 Hz), two geminal coupled oxygenated-methylene protons at δH 4.16 (1H, dd, J = 9.8, 5.0 Hz) and 4.39 (1H, dd, J = 9.8, 7.2 Hz), two methyl signals at δH 1.04 (3H, s) and 1.84 (3H, s). The 13C-NMR spectrum showed 21 carbon signals, including two tertiary methyl carbons (δC 19.8 and 25.0), an oxygenated methylene carbon (δC 70.0), three oxygenated methine carbons (δC 70.7, 78.3, and 98.7), four olefinic carbons (δC 119.4, 130.2, 141.1 and 145.5), an acetalic carbon (δC 113.6), and a carbonyl carbon (δC 179.6), which exhibited the characteristics of 13,14:14,15-disecopregnane-type steroidal glycoside. Comparison of the spectral data of 2 with those of paniculatumoside B, a new C21 steroidal glycoside isolated from the dried root of C. paniculatum (Li et al., 2004), the changes of the chemical shifts in C-2 (+2.5 ppm), C-3 (-6.4 ppm), C-4 (+4.0 ppm) showed that it has no linkage of the sugar moiety at the C-3 hydroxyl group of the aglycone. Thus, the structure of 2 was established as neocynapanogenin C, the aglycone of paniculatumoside B. It should be noted that compound 2 was isolated for the first time from the natural source.

Compounds 3 and 4 were identified by comparing the 1H- and 13C-NMR, as well as MS spectra with those reported in the literatures. They were determined to be cynapanoside A (3) (Sugama et al., 1986) and cynatratoside A (4) (Zhang et al., 1985).


This project was supported by the National Natural Science Foundation of China under Grant 81273396; Shandong Province Higher Educational Science and Technology Program under Grant J15LM12.


Bai, H., Li, W., Koike, K., Satou, T., Chen, Y.J., Nikaido, T., 2005. Cynanosides A–J, ten novel pregnane glycosides from Cynanchum atratum. Tetrahedron 61, 5797-5811. [ Links ]

Choi, J.H., Jung, B.H., Kang, O.H., Choi, H.J., Park, P.S., Cho, S.H., Kim, Y.C., Sohn, D.H., Park, H., Lee, J.H., Kwon, D.Y., 2006. The anti-inflammatory and anti-nociceptive effects of ethyl acetate fraction of cynanchi paniculati radix. Biol. Pharm. Bull. 29, 971-975. [ Links ]

Chu, W.X., Liu, X.H., Liu, K., Huo, L.N., Yao, H.L., Gao, Q., Gao, H., Wang, W., 2015. Chemical constituents from active fraction in roots and rhizomes of Cynanchum paniculatum with reversal activity of multidrug resistance. Chin. Tradit. Herbal Drugs 18, 2674-2679. [ Links ]

Fu, M., Wang, D.Y., Hu, X., Guo, M.Q., 2015. Chemical constituents from Cynanchum paniculatum. J. Chin. Med. Mater. 38, 97-100. [ Links ]

Jang, E.J., Kim, H.K., Jeong, H., Lee, Y.S., Jeong, M.G., Bae, S.J., Kim, S., Lee, S.K., Hwang, E.S., 2014. Anti-adipogenic activity of the naturally occurring phenanthroindolizidine alkaloid antofine via direct suppression of PPARγ expression. Chem. Biodivers. 11, 962-969. [ Links ]

Jiang, Y., Li, B.T., 1977. Angiospermae, Dicotyledonae, Apocynaceae and Asclepiadaceae. Flora of China Editorial Committee Flora of China, vol. 63. Science Press, Beijing, pp. 351–353. [ Links ]

Kim, C.S., Oh, J.Y., Choi, S.U., Lee, K.R., 2013b. Chemical constituents from the roots of Cynanchum paniculatum and their cytotoxic activity. Carbohydr. Res. 381, 1-5. [ Links ]

Kim, E.H., Min, H.Y., Chung, H.J., Song, J., Park, H.J., Kim, S., Lee, S.K., 2012. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. Food Chem. Toxicol. 50, 1060-1065. [ Links ]

Kim, M.G., Yang, J.Y., Lee, H.S., 2013a. Acaricidal potentials of active properties isolated from Cynanchum paniculatum and acaricidal changes by introducing functional radicals. J. Agric. Food Chem. 61, 7568-7573. [ Links ]

Li, S.L., Tan, H., Shen, Y.M., Kazuyoshi, K., Hao, X.J., 2004. A pair of new C-21 steroidal glycoside epimers from the roots of Cynanchum paniculatum. J. Nat. Prod. 67, 82-84. [ Links ]

Li, X.F., Guo, Y.J., Zhang, D.M., Chen, Z., Wei, X., Li, Y.H., Zhang, S.L., Tao, J.Y., Dong, J.H., Mei, Y.W., Li, L.L., Zhao, L., 2012. Protective activity of the ethanol extract of Cynanchum paniculatum (Bunge) Kitagawa on treating herpes simplex encephalitis. Int. J. Immunopathol. Pharmacol. 25, 259-266. [ Links ]

Ma, X.X., Jiang, F.T., Yang, Q.X., Liu, X.H., Zhang, Y.J., Yang, C.R., 2007. New pregnane glycosides from the roots of Cynanchum otophyllum. Steroids 72, 778-786. [ Links ]

Niu, Y.L., Chen, X., Wu, Y., Jiang, H.Q., Zhang, X.L., Li, E.T., Li, Y.Y., Zhou, H.L., Liu, J.G., Wang, D.Y., 2015. Chemical constituents from Cynanchum paniculatum (Bunge) Kitag. Biochem. Syst. Ecol. 61, 139-142. [ Links ]

Sugama, K., Hayashi, K., Mitsuhashi, H., Kaneko, K., 1986. Studies on the constituents of Asclepiadaceae plants. LXVI. The structures of three new glycosides, cynapanoside A, B, and C, from the Chinese drug XU-Chang_Qing, Cynanchum paniculatum Kitagawa. Chem. Pharm. Bull. 34, 4500-4507. [ Links ]

Weon, J.B., Ko, H.J., Ma, C.J., 2013. The ameliorating effects of 2,3-dihydroxy-4-methoxyacetophenone on scopolamine-induced memory impairment in mice and its neuroprotective activity. Bioorg. Med. Chem. Lett. 23, 6732-6736. [ Links ]

Yang, Q.X., Ge, Y.C., Huang, X.Y., Sun, Q.Y., 2011. Cynanauriculoside C–E, three new antidepressant pregnane glycosides from Cynanchum auriculatum. Phytochem. Lett. 4, 170-175. [ Links ]

Zhang, Z.X., Zhou, J., Hayashi, K., Mitsuhashi, H., 1985. Studies on the constituents of Asclepiadaceae plants. LVIII. The constituents of five glycosides, cynatratoside-A, -B, -C, -D, and–E, from the Chinese drug Pai-Wei, Cynanchum atratum Bunge Chem. Pharm. Bull. 33, 1507-1514. [ Links ]

Zhu, N.Q., Wang, M.F., Kikuzaki, H., Nakatani, N., Ho, C.T., 1999. Two C21-steroidal glycosides isolated from Cynanchum stauntoi. Phytochemistry 52, 1351-1355. [ Links ]

Received: March 16, 2016; Accepted: June 30, 2016

* Corresponding author. (W. Wang).

Authors’ contributions

HG, WXC, HLY, and QG performed the extraction, isolation, and elucidation of the constituents. KL, YL, and XHL contributed to checking and confirming all of the procedures of the isolation and identification. WW designed the study, supervised the laboratory work, and contributed to critical reading of the manuscript. All the authors have read the final manuscript and approved the submission.

Conflicts of interest

The authors declare no conflicts of interest.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.